1dfh
From Proteopedia
Line 1: | Line 1: | ||
[[Image:1dfh.jpg|left|200px]] | [[Image:1dfh.jpg|left|200px]] | ||
- | + | <!-- | |
- | + | The line below this paragraph, containing "STRUCTURE_1dfh", creates the "Structure Box" on the page. | |
- | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
- | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
- | + | or leave the SCENE parameter empty for the default display. | |
- | | | + | --> |
- | | | + | {{STRUCTURE_1dfh| PDB=1dfh | SCENE= }} |
- | + | ||
- | + | ||
- | }} | + | |
'''X-RAY STRUCTURE OF ESCHERICHIA COLI ENOYL REDUCTASE WITH BOUND NAD AND THIENO-DIAZABORINE''' | '''X-RAY STRUCTURE OF ESCHERICHIA COLI ENOYL REDUCTASE WITH BOUND NAD AND THIENO-DIAZABORINE''' | ||
Line 23: | Line 20: | ||
==Reference== | ==Reference== | ||
A mechanism of drug action revealed by structural studies of enoyl reductase., Baldock C, Rafferty JB, Sedelnikova SE, Baker PJ, Stuitje AR, Slabas AR, Hawkes TR, Rice DW, Science. 1996 Dec 20;274(5295):2107-10. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/8953047 8953047] | A mechanism of drug action revealed by structural studies of enoyl reductase., Baldock C, Rafferty JB, Sedelnikova SE, Baker PJ, Stuitje AR, Slabas AR, Hawkes TR, Rice DW, Science. 1996 Dec 20;274(5295):2107-10. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/8953047 8953047] | ||
- | [[Category: Enoyl-[acyl-carrier-protein] reductase (NADH)]] | ||
[[Category: Escherichia coli]] | [[Category: Escherichia coli]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
Line 29: | Line 25: | ||
[[Category: Rafferty, J B.]] | [[Category: Rafferty, J B.]] | ||
[[Category: Rice, D W.]] | [[Category: Rice, D W.]] | ||
- | [[Category: | + | [[Category: Diazaborine]] |
- | [[Category: | + | [[Category: Lipid biosynthesis]] |
- | [[Category: | + | [[Category: Oxidoreductase]] |
- | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 13:47:44 2008'' | |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + |
Revision as of 10:47, 2 May 2008
X-RAY STRUCTURE OF ESCHERICHIA COLI ENOYL REDUCTASE WITH BOUND NAD AND THIENO-DIAZABORINE
Overview
Enoyl reductase (ENR), an enzyme involved in fatty acid biosynthesis, is the target for antibacterial diazaborines and the front-line antituberculosis drug isoniazid. Analysis of the structures of complexes of Escherichia coli ENR with nicotinamide adenine dinucleotide and either thienodiazaborine or benzodiazaborine revealed the formation of a covalent bond between the 2' hydroxyl of the nicotinamide ribose and a boron atom in the drugs to generate a tight, noncovalently bound bisubstrate analog. This analysis has implications for the structure-based design of inhibitors of ENR, and similarities to other oxidoreductases suggest that mimicking this molecular linkage may have generic applications in other areas of medicinal chemistry.
About this Structure
1DFH is a Single protein structure of sequence from Escherichia coli. Full crystallographic information is available from OCA.
Reference
A mechanism of drug action revealed by structural studies of enoyl reductase., Baldock C, Rafferty JB, Sedelnikova SE, Baker PJ, Stuitje AR, Slabas AR, Hawkes TR, Rice DW, Science. 1996 Dec 20;274(5295):2107-10. PMID:8953047 Page seeded by OCA on Fri May 2 13:47:44 2008